Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRIUMPH: Eculizumab in PNH
NCT00112983Phase 3Completed
- Sponsor
- UCLA Jonsson Comprehensive Cancer Center
- Start
- Nov 2004
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of eculizumab in paroxysmal nocturnal hemoglobinuria (PNH), sponsored by UCLA Jonsson Comprehensive Cancer Center. Started Nov 2004; status: completed.
02
Drugs
eculizumab
03
Conditions
paroxysmal nocturnal hemoglobinuria (PNH)
Beyond the preview
Go deeper on NCT00112983.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00112983.